SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories informs about conference call

12 Nov 2025 Evaluate
Further to intimation dated 6th November, 2025 and in accordance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that the Conference Call to discuss the Company’s Q2FY26 earnings and business update which was scheduled to held on Thursday, 13th November, 2025 from 16.00 hrs IST has been preponed by 30 minutes and now shall be held from 15:30 hrs onwards. The company has enclosed the revised conference call / invite details.

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1468.00 6.75 (0.46%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×